- Our ambition at Anthony Nolan is that every patient receives the care and support they need before, during and after a stem cell transplant, for as long as necessary and no…
- Scott was the 9th patient in the UK to participate in a CAR T-cell therapy trial, following a relapse from Acute lymphoblastic leukaemia (ALL). Scott shares with us how this…
Reducing the risk of infection from cosmetic products and toiletries after your stem cell transplant
In this blog, our Science Communications Manager, Jonathan Kay, looks at how make-up products could cause infections post-transplant and the steps you can take to help reduce the…- Anthony Nolan is proud to announce the launch of SEQoL, which stands for Scaled collection of socioEconomic and Quality of Life data from patients undergoing stem cell transplants…
- Our research donors A hugely important part of Anthony Nolan’s work is our provision of stem cells to researchers working in hospitals, universities, and pharmaceutical…
- Blood cancer research highlights For Blood Cancer Awareness Month, we’re highlighting some of the standout blood cancer research that has been happening around the…
- A stem cell transplant is a curative treatment for blood cancers and blood disorders. The procedure involves replacing a patient’s stem cells with those of a tissue type-matched…
- Anthony Nolan is launching its new research strategy, to help us provide the biggest impact possible for patients. Our researchers are at the heart of this strategy, driving our…
- This year marks the 25th year of operation of the world’s only centralised database of all the known variants of the HLA genes – the IPD-IMGT/HLA Database – which is managed by…
- (Pictured: Dr Beth Ollington) February 11 marks the International Day of Women and Girls in Science, and what better way to celebrate it than by getting to know our…